Eli Lilly Drops CVS Drug Plan for Workers After Novo Obesity Deal

Eli Lilly has decided to drop the CVS drug plan for its workers following the Novo obesity deal. This decision comes after a recent agreement between Lilly and Novo related to obesity. The move is significant for Lilly employees who will no longer have access to the CVS drug plan. The decision was reported by Bloomberg News.
Related stocks
 
 
Related News

Xiaomi releases the 2025 Double 11 battle report, and the cumulative payment amount through all channels exceeds 29 billion yuan

老虎资讯综合·11月 12, 2025
Xiaomi releases the 2025 Double 11 battle report, and the cumulative payment amount through all channels exceeds 29 billion yuan

Changes in Hong Kong stocks | Xiaomi Group-W (01810) rose more than 3%, the cumulative payment amount of Double Eleven omni-channel exceeded 29 billion yuan

智通财经·11月 12, 2025
Changes in Hong Kong stocks | Xiaomi Group-W (01810) rose more than 3%, the cumulative payment amount of Double Eleven omni-channel exceeded 29 billion yuan

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10